Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01162954 | Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers | PHASE1 | COMPLETED | - | — | — | Sep 1, 2008 | Mar 1, 2009 | Oct 1, 2014 | 1 | South Korea |
| Arm | Type | Description |
|---|---|---|
| DA-6034 | EXPERIMENTAL | - |
| Placebo | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| DA-6034 | DRUG | - |
| Placebo | DRUG | - |
Inclusion Criteria: * 20-50 year-old healthy subjects Exclusion Criteria: * Presence or history of dry eye or other ocular or systemic diseases * Corrected visual acuity less than 20/40 in either eye at the screening * Any eye surgery or laser eye surgery within the past six months * Intraocular ...